Dataset Information


Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3.

ABSTRACT: Inactivation of the von Hippel-Lindau (VHL) tumor suppressor gene is linked to the development of tumors of the eyes, kidneys, and central nervous system. VHL encodes two gene products, pVHL30 and pVHL19, of which one, pVHL30, associates functionally with microtubules (MTs) to regulate their stability. Here we report that pVHL30 is a novel substrate of glycogen synthase kinase 3 (GSK3) in vitro and in vivo. Phosphorylation of pVHL on serine 68 (S68) by GSK3 requires a priming phosphorylation event at serine 72 (S72) mediated in vitro by casein kinase I. Functional analysis of pVHL species carrying nonphosphorylatable or phosphomimicking mutations at S68 and/or S72 reveals a central role for these phosphorylation events in the regulation of pVHL's MT stabilization (but not binding) activity. Taken together, our results identify pVHL as a novel priming-dependent substrate of GSK3 and suggest a dual-kinase mechanism in the control of pVHL's MT stabilization function. Since GSK3 is a component of multiple signaling pathways that are altered in human cancer, our results further imply that normal operation of the GSK3-pVHL axis may be a critical aspect of pVHL's tumor suppressor mechanism through the regulation of MT dynamics.

SUBMITTER: Hergovich A 

PROVIDER: S-EPMC1592755 | BioStudies | 2006-01-01

REPOSITORIES: biostudies

Similar Datasets

2003-01-01 | S-EPMC230328 | BioStudies
2012-01-01 | S-EPMC3332038 | BioStudies
2015-01-01 | S-EPMC4647558 | BioStudies
2007-01-01 | S-EPMC2128776 | BioStudies
2003-01-01 | S-EPMC150743 | BioStudies
1000-01-01 | S-EPMC3570507 | BioStudies
1000-01-01 | S-EPMC2963357 | BioStudies
2016-01-01 | S-EPMC4907096 | BioStudies
2016-01-01 | S-EPMC5312400 | BioStudies
2016-01-01 | S-EPMC4987997 | BioStudies